ChiCTR2500101236 版本V1.0 版本创建时间2025/04/22 14:23:11 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500101236 

最近更新日期:

Date of Last Refreshed on:

2025-04-22 14:22:53 

注册时间:

Date of Registration:

2025-04-22 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

回顾性队列研究分析围术期因素与术后认知功能障碍关联性

Public title:

A Retrospective Cohort Study on Perioperative Factors Associated with Postoperative Cognitive Dysfunction

注册题目简写:

English Acronym:

研究课题的正式科学名称:

回顾性队列研究分析围术期因素与术后认知功能障碍关联性

Scientific title:

A Retrospective Cohort Study on Perioperative Factors Associated with Postoperative Cognitive Dysfunction

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王平 

研究负责人:

王平 

Applicant:

Wang Ping 

Study leader:

Wang Ping 

申请注册联系人电话:

Applicant telephone:

+86 181 3228 6739

研究负责人电话:

Study leader's
telephone:

+86 181 3228 6739

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

waiting9989@163.com

研究负责人电子邮件:

Study leader's E-mail:

waiting9989@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河北省石家庄市长安区石家庄第四医院

研究负责人通讯地址:

河北省石家庄市长安区石家庄第四医院

Applicant address:

The Fourth Hospital of Shijiazhuang, Chang'an District, Shijiazhuang, Hebei Province, China

Study leader's address:

The Fourth Hospital of Shijiazhuang, Chang'an District, Shijiazhuang, Hebei Province, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

石家庄市第四医院

Applicant's institution:

The Fourth Hospital of Shijiazhuang

研究负责人所在单位:

石家庄市第四医院

Affiliation of the Leader:

The Fourth Hospital of Shijiazhuang

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

20250041

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

石家庄市第四医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of The Fourth Hospital of Shijiazhuang

伦理委员会批准日期:

Date of approved by ethic committee:

2025-03-11 00:00:00

伦理委员会联系人:

苏建强

Contact Name of the ethic committee:

Su Jianqiang

伦理委员会联系地址:

河北省石家庄市长安区石家庄第四医院

Contact Address of the ethic committee:

The Fourth Hospital of Shijiazhuang, Chang'an District, Shijiazhuang, Hebei Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 311 8528 1765

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

石家庄市第四医院

Primary sponsor:

The Fourth Hospital of Shijiazhuang

研究实施负责(组长)单位地址:

河北省石家庄市长安区石家庄第四医院

Primary sponsor's address:

The Fourth Hospital of Shijiazhuang, Chang'an District, Shijiazhuang, Hebei Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河北省

市(区县):

石家庄市

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

石家庄市第四医院

具体地址:

河北省石家庄市长安区石家庄第四医院

Institution
hospital:

The Fourth Hospital of Shijiazhuang

Address:

The Fourth Hospital of Shijiazhuang, Chang'an District, Shijiazhuang, Hebei Province, China

经费或物资来源:

Source(s) of funding:

None

研究疾病:

认知功能障碍  

Target disease:

Postoperative Cognitive Dysfunction

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

分析发生术后认知功能障碍患者的围术期因素,确定其危险因素。  

Objectives of Study:

This study aims to investigate perioperative contributing factors and establish independent risk factors for postoperative cognitive dysfunction (POCD).

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

行腔镜下全子宫切除术、腹腔镜下单侧(或双侧)附件切除术、腹腔镜下盆腔脓肿清除术、腹腔镜下全子宫(包含广泛全子宫)+双侧附件切除术+盆腔淋巴结清扫术(包含腹主动脉旁淋巴清扫)、腹腔镜辅助下阴式全子宫切除术、腹腔镜辅助下盆底重建术、腹腔镜下骶骨悬吊等,年龄大于65岁以上老年患者。

Inclusion criteria

Total hysterectomy under laparoscopy, laparoscopic unilateral (or bilateral) adnexectomy, laparoscopic pelvic abscess clearance, laparoscopic total hysterectomy (including radical total hysterectomy) + bilateral adnexectomy + pelvic lymph node dissection (including para-aortic lymph node dissection), laparoscopy-assisted vaginal total hysterectomy, laparoscopy-assisted pelvic floor reconstruction, laparoscopic sacral colpopexy, etc.older patients over 65 years old.

排除标准:

1.中枢神经系统和(或)精神心理疾病; 2.语言交流障碍; 3.针对受教育程度,简易智力状态检查(MMSE)评分,文盲<=17分,小学文化者<=20分,初中及以上文化水平者<=24; 4.近期服用镇静剂、抗抑郁、糖皮质激素类药物; 5.严重肝肾功能损害; 6.有严重的视力或听力障碍。

Exclusion criteria:

1.Exclusion criteria comprised CNS/psychiatric diseases; 2.Language barriers; 3.MMSE scores below education-adjusted thresholds (illiterate <=17; primary school <=20; secondary education <=24); 4.Recent use of sedatives, antidepressants, glucocorticoids; 5.Severe liver or kidney function impairment; 6. Severe visual or auditory impairment.

研究实施时间:

Study execute time:

From 2025-05-01 00:00:00 To 2027-05-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-05-01 00:00:00 To 2027-05-01 00:00:00

干预措施:

Interventions:

组别:

POCD组和非POCD组

样本量:

800

Group:

POCD group and non-POCD group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河北省 

市(区县):

石家庄市 

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

石家庄市第四医院 

单位级别:

三甲 

Institution
hospital:

The Fourth Hospital of Shijiazhuang

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后认知功能障碍

指标类型:

主要指标

Outcome:

Postoperative cognitive dysfunction

Type:

Primary indicator

测量时间点:

术后1天和术后7天

测量方法:

MMSE量表评分

Measure time point of outcome:

Postoperative day 1 and Postoperative day 7

Measure method:

Scored using the MMSE scale

指标中文名:

术后谵妄

指标类型:

主要指标

Outcome:

Postoperative delirium

Type:

Primary indicator

测量时间点:

术后1天和术后7天

测量方法:

意识模糊评估量表

Measure time point of outcome:

Postoperative day 1 and Postoperative day 7

Measure method:

Confusion Assessment Method

指标中文名:

术前并发症

指标类型:

次要指标

Outcome:

Preoperative complication

Type:

Secondary indicator

测量时间点:

术前

测量方法:

术前访视患者详细记录于病历

Measure time point of outcome:

Preoperative

Measure method:

Preoperative patient visits were recorded in detail in medical records

指标中文名:

血红蛋白

指标类型:

次要指标

Outcome:

Hemoglobin

Type:

Secondary indicator

测量时间点:

术前

测量方法:

血液分析仪

Measure time point of outcome:

Preoperative

Measure method:

Blood analyzer

指标中文名:

麻醉用药量

指标类型:

次要指标

Outcome:

The amount of anesthetic used

Type:

Secondary indicator

测量时间点:

术毕

测量方法:

麻醉记录单

Measure time point of outcome:

End of operation

Measure method:

Anesthesia sheet

指标中文名:

脑电双频指数

指标类型:

次要指标

Outcome:

bispectral index

Type:

Secondary indicator

测量时间点:

术中

测量方法:

麻醉深度监护仪

Measure time point of outcome:

During operation

Measure method:

anaesthesia depth monitor

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

NA

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

None

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-04-22 14:22:53